Area of research
Molecular Biology · Hematology
Research interest
Research interests include Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Genomics and Chromatin Dynamics, and Cancer, Hypoxia, and Metabolism.
Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication
Targeting KDM4 for treating PAX3-FOXO1–driven alveolar rhabdomyosarcoma
Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma
Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancer
Co-inhibition of BET and proteasome enhances ER stress and Bim-dependent apoptosis with augmented cancer therapeutic efficacy
Specificity protein 1: Its role in colorectal cancer progression and metastasis
Development of GLUT4-selective antagonists for multiple myeloma therapy
Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax
In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy
Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin